W8A Stock Overview
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 1/6 |
Dividends | 2/6 |
Walgreens Boots Alliance, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$16.52 |
52 Week High | US$32.06 |
52 Week Low | US$16.42 |
Beta | 0.75 |
1 Month Change | -12.92% |
3 Month Change | -21.45% |
1 Year Change | -48.00% |
3 Year Change | -62.11% |
5 Year Change | n/a |
Change since IPO | -40.14% |
Recent News & Updates
Recent updates
Shareholder Returns
W8A | DE Consumer Retailing | DE Market | |
---|---|---|---|
7D | -0.04% | 1.9% | 1.7% |
1Y | -48.0% | -34.9% | 2.3% |
Return vs Industry: W8A underperformed the German Consumer Retailing industry which returned -34.9% over the past year.
Return vs Market: W8A underperformed the German Market which returned 2.3% over the past year.
Price Volatility
W8A volatility | |
---|---|
W8A Average Weekly Movement | 4.4% |
Consumer Retailing Industry Average Movement | 5.9% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.1% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: W8A's share price has been volatile over the past 3 months.
Volatility Over Time: W8A's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1909 | 268,500 | Tim Wentworth | www.walgreensbootsalliance.com |
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S.
Walgreens Boots Alliance, Inc. Fundamentals Summary
W8A fundamental statistics | |
---|---|
Market cap | €14.33b |
Earnings (TTM) | -€5.63b |
Revenue (TTM) | €134.84b |
0.1x
P/S Ratio-2.5x
P/E RatioIs W8A overvalued?
See Fair Value and valuation analysisEarnings & Revenue
W8A income statement (TTM) | |
---|---|
Revenue | US$144.60b |
Cost of Revenue | US$117.72b |
Gross Profit | US$26.88b |
Other Expenses | US$32.91b |
Earnings | -US$6.04b |
Last Reported Earnings
Feb 29, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -7.00 |
Gross Margin | 18.59% |
Net Profit Margin | -4.18% |
Debt/Equity Ratio | 61.7% |
How did W8A perform over the long term?
See historical performance and comparison